Clinical Trial Update: Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose trial update of a combination therapy in subjects with multiple myeloma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Cancer, Various, NOS | Phase 1 | Status: COMPLETED